Results 11 to 20 of about 740,437 (210)

Vasoactive-Inotropic Score and Vasoactive-Ventilation-Renal Score as Outcome Predictors for Children on Extracorporeal Membrane Oxygenation

open access: yesFrontiers in Pediatrics, 2021
We aimed to determine the association of vasoactive-inotropic score (VIS) and vasoactive-ventilation-renal (VVR) score with in-hospital mortality and functional outcomes at discharge of children who receive ECMO.
Ira Shukla   +3 more
doaj   +1 more source

A Comprehensive Account on Recent Progress in Pharmacological Activities of Benzimidazole Derivatives

open access: yesFrontiers in Pharmacology, 2021
Nowadays, nitrogenous heterocyclic molecules have attracted a great deal of interest among medicinal chemists. Among these potential heterocyclic drugs, benzimidazole scaffolds are considerably prevalent.
Shejuti Rahman Brishty   +5 more
doaj   +1 more source

The role of urate and xanthine oxidase in vascular oxidative stress:Future directions [PDF]

open access: yes, 2009
Vascular oxidative stress has been shown to be a potent factor in the pathophysiology of endothelial dysfunction. Despite current optimal evidence-based therapy, mortality from various cardiovascular disorders remains high.
George, Jacob, Struthers, Allan
core   +5 more sources

The impact of cardiovascular drugs on the efficacy of local anesthesia in dentistry

open access: yesBiomedical Papers, 2016
Background and Aim. Drugs used chronically by patients with diseases of the cardiovascular system (group C of the ATC classification) may act on adrenergic receptors and/or certain ion channels, which gives them the potential to interact with the action
Мarko J. Milosavljevic   +1 more
doaj   +1 more source

Natural AMPK Activators in Cardiovascular Disease Prevention

open access: yesFrontiers in Pharmacology, 2022
Cardiovascular diseases (CVD), as a life-threatening global disease, is receiving worldwide attention. Seeking novel therapeutic strategies and agents is of utmost importance to curb CVD.
Reza Heidary Moghaddam   +8 more
doaj   +1 more source

Diabetes: how to manage cardiovascular risk in secondary prevention patients

open access: yesDrugs in Context, 2022
Atherosclerotic cardiovascular disease (ASCVD) commonly affects people with type 2 diabetes (T2D). Historically, traditional cardiovascular (CV) risk-lowering therapies in patients with T2D and ASCVD have included antiplatelet agents, blood pressure ...
Sarah L Anderson, Joel C Marrs
doaj   +1 more source

Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms [PDF]

open access: yes, 2018
Hypertension and type 2 diabetes are common comorbidities. Hypertension is twice as frequent in patients with diabetes compared with those who do not have diabetes.
Guzik, Tomasz J.   +2 more
core   +1 more source

Call to action: Understanding the differences in the use of SGLT-2 inhibitors and GLP-1 receptor agonists

open access: yesAmerican Journal of Preventive Cardiology, 2023
Cardiovascular disease remains one of the most prominent global health problems and has been demonstrated to disproportionally affect certain communities.
Apurva Khedagi   +9 more
doaj   +1 more source

Drug treatment of hypertension: focus on vascular health [PDF]

open access: yes, 2016
Hypertension, the most common preventable risk factor for cardiovascular disease and death, is a growing health burden. Serious cardiovascular complications result from target organ damage including cerebrovascular disease, heart failure, ischaemic heart
Cameron, Alan C.   +2 more
core   +1 more source

Production and market comparison of urokinase and streptokinase as effective and cheap fibrinolytic agents for treatment of cardiovascular diseases

open access: yesActa Scientiarum: Technology, 2022
 Failure of hemostasis and the formation of blood clots in the arteries are the main reasons that provoke the onset of cardiovascular diseases (CVDs) such as myocardial infarction and ischemic stroke.
Ali Nawaz   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy